Literature DB >> 22052348

Polyglutamine misfolding in yeast: toxic and protective aggregation.

Martin L Duennwald1.   

Abstract

Protein misfolding is associated with many human diseases, including neurodegenerative diseases, such as Alzheimer disease, Parkinson disease and Huntington disease. Protein misfolding often results in the formation of intracellular or extracellular inclusions or aggregates. Even though deciphering the role of these aggregates has been the object of intense research activity, their role in protein misfolding diseases is unclear. Here, I discuss the implications of studies on polyglutamine aggregation and toxicity in yeast and other model organisms. These studies provide an excellent experimental and conceptual paradigm that contributes to understanding the differences between toxic and protective trajectories of protein misfolding. Future studies like the ones discussed here have the potential to transform basic concepts of protein misfolding in human diseases and may thus help to identify new therapeutic strategies for their treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052348      PMCID: PMC4012402          DOI: 10.4161/pri.18071

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  74 in total

1.  Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast.

Authors:  Benjamin Dehay; Anne Bertolotti
Journal:  J Biol Chem       Date:  2006-09-14       Impact factor: 5.157

Review 2.  Structural models of amyloid-like fibrils.

Authors:  Rebecca Nelson; David Eisenberg
Journal:  Adv Protein Chem       Date:  2006

Review 3.  On the structural definition of amyloid fibrils and other polypeptide aggregates.

Authors:  M Fändrich
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

4.  Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains.

Authors:  Anatoli B Meriin; XiaoQian Zhang; Ilya M Alexandrov; Alexandra B Salnikova; Michael D Ter-Avanesian; Yury O Chernoff; Michael Y Sherman
Journal:  FASEB J       Date:  2007-03-06       Impact factor: 5.191

Review 5.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

Review 6.  Screening for genetic modifiers of amyloid toxicity in yeast.

Authors:  Flaviano Giorgini; Paul J Muchowski
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

7.  Flanking sequences profoundly alter polyglutamine toxicity in yeast.

Authors:  Martin L Duennwald; Smitha Jagadish; Paul J Muchowski; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 8.  Amyloid in neurodegenerative diseases: friend or foe?

Authors:  Katie J Wolfe; Douglas M Cyr
Journal:  Semin Cell Dev Biol       Date:  2011-03-31       Impact factor: 7.727

9.  Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity.

Authors:  Amber L Southwell; Ali Khoshnan; Denise E Dunn; Charles W Bugg; Donald C Lo; Paul H Patterson
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

Review 10.  The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging.

Authors:  Heather R Brignull; James F Morley; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 3.650

View more
  15 in total

1.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

Review 2.  Prions in yeast.

Authors:  Susan W Liebman; Yury O Chernoff
Journal:  Genetics       Date:  2012-08       Impact factor: 4.562

3.  Pharmacological tuning of heat shock protein 70 modulates polyglutamine toxicity and aggregation.

Authors:  Sidhartha M Chafekar; Susanne Wisén; Andrea D Thompson; AnaLisa Echeverria; Gladis M Walter; Christopher G Evans; Leah N Makley; Jason E Gestwicki; Martin L Duennwald
Journal:  ACS Chem Biol       Date:  2012-06-22       Impact factor: 5.100

4.  Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.

Authors:  Justin Y Chen; Miloni Parekh; Hadear Seliman; Dariya Bakshinskaya; Wei Dai; Kelvin Kwan; Kuang Yu Chen; Alice Y C Liu
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

5.  Deciphering the roles of trehalose and Hsp104 in the inhibition of aggregation of mutant huntingtin in a yeast model of Huntington's disease.

Authors:  Rajeev Kumar Chaudhary; Jay Kardani; Kuljit Singh; Ruchira Banerjee; Ipsita Roy
Journal:  Neuromolecular Med       Date:  2013-11-19       Impact factor: 3.843

6.  Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast.

Authors:  He Gong; Nina V Romanova; Kim D Allen; Pavithra Chandramowlishwaran; Kavita Gokhale; Gary P Newnam; Piotr Mieczkowski; Michael Y Sherman; Yury O Chernoff
Journal:  PLoS Genet       Date:  2012-04-19       Impact factor: 5.917

Review 7.  Yeast and the AIDS virus: the odd couple.

Authors:  Marie-Line Andréola; Simon Litvak
Journal:  J Biomed Biotechnol       Date:  2012-06-17

8.  Impaired heat shock response in cells expressing full-length polyglutamine-expanded huntingtin.

Authors:  Sidhartha M Chafekar; Martin L Duennwald
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

9.  The Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular Model.

Authors:  Marcella Bonanomi; Cristina Visentin; Gaetano Invernizzi; Paolo Tortora; Maria Elena Regonesi
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 10.  Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins.

Authors:  Ralf J Braun
Journal:  Front Mol Neurosci       Date:  2015-03-12       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.